Devene Prince, PharmD

PharmD with PGY-1 residency training and a strong background in primary care, psychiatry, and biologics. Currently a U.S. Medical Affairs Fellow at GSK, specializing in biologic therapies for respiratory diseases, with expertise in scientific exchange, data analysis, KOL engagement, and competitive intelligence. Published author with research experience in real-world evidence and clinical outcomes, contributing to peer-reviewed literature. Skilled in translating complex clinical data into strategic insights that drive medical strategy and decision-making. Passionate about bridging scientific innovation with patient care to advance biologics in respiratory and immunology.

• Howard University Student Assessment Committee, 09/01/19, 05/31/23, Evaluated academic programs and formulated annual assessment plans.
• Vice President, Phi Delta Chi (PDC) Pharmaceutical Fraternity, 09/01/20, 09/30/21, Organized professional events and coordinated fraternity activities.
• Pre-Pharmacy Chairwoman, Student National Pharmaceutical Association (SNPhA), 08/01/20, 09/30/21, Conducted events promoting pharmacy at high schools and coordinated pre-pharmacy programs.

• Idaho Pharmacist License, P11038, 10/01/23, Present
• Advanced Cardiac Life Support, 07/01/23, Present
• Immunization Certification, 04/01/20, Present
• HIPAA Certification, 04/01/19, Present

• PharmD
• RPh
• BCPS Candidate

• Evaluating the Incidence Rate of Amputations in Veterans Hospitalized With COVID-19, Eastern States Pharmacy Residency Conference, 05/01/24
• Benefits of Using Virtual Reality to Teach in Pharmacy Compounding Lab, ASHP Midyear Clinical Meeting, 12/01/22

• Evaluating The Incidence Rate of Amputations in Veterans Hospitalized With COVID-19, Salem Veterans Affairs Medical Center, Tanvi Patil, PharmD, BCPS, DPLA, Aliza Lee, PharmD
• Evaluating Appropriateness of Urate Lowering Therapy in Gout Patients (PGY1 MUE), Tanvi Patil, PharmD, BCPS, DPLA, et al.